Rosamond Deegan

CEO at OMass Therapeutics - Oxford, ENG, UK

Rosamond Deegan's Contact Details
HQ
N/A
Location
Company
OMass Therapeutics
Rosamond Deegan's Company Details
OMass Therapeutics logo, OMass Therapeutics contact details

OMass Therapeutics

Oxford, ENG, UK • 50 - 99 Employees
BioTech/Drugs

OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Science Enterprises.

N/A
Details about OMass Therapeutics
Frequently Asked Questions about Rosamond Deegan
Rosamond Deegan currently works for OMass Therapeutics.
Rosamond Deegan's role at OMass Therapeutics is CEO.
Rosamond Deegan's email address is ***@omass.com. To view Rosamond Deegan's full email address, please signup to ConnectPlex.
Rosamond Deegan works in the Biotechnology industry.
Rosamond Deegan's colleagues at OMass Therapeutics are Amir Feizi, Kleitos Sokratous, Kiran Bountra, Antonio Biasutto, Fernando Almeida, Elvira Diamantopoulou, Max Hodges and others.
Rosamond Deegan's phone number is N/A
See more information about Rosamond Deegan